Do you have trouble sleeping in the morning or in the middle of the night? This can affect your risk of developing dementia.

Published Date: 08 Mar 2023

Along with growing evidence of poor sleep and cognitive impairment, a new study has found an association between three measures of sleep and the risk of developing dementia by age 10. ...

Read Full News

Latest News

The Paradigm Shift in Neuro-Oncology: Precision Decision-Making for IDH1/2 Mutated Gliomas

The Paradigm Shift in Neuro-Oncology: Precision Decision-Making for IDH1/2 Mutated Gliomas

All that Glitters Isn't Gold: An Exploration of Parkinson's Disease Mimics

All that Glitters Isn't Gold: An Exploration of Parkinson's Disease Mimics

FDA Clears Blood Test to Detect Alzheimer's in Primary and Specialty Care

Assay measures phosphorylated tau 217, an indicator of amyloid pathology

Dementia Drug Helpful With Lupus Brain Fog

Cognitive function improved in small placebo-controlled trial

Controversial Neurologist to Lead NIH Unit; Hunter Trial Halted; Dads and Valproate

News and commentary from the world of neurology and neuroscience

More NFL Players Have CTE Than Previously Thought, Study Suggests

At least 1 in 4 pro players who died from 2016 to 2021 had the progressive brain disorder

Todays Updates

Transforming Perioperative MIBC Care in Community Practice: Navigating Emerging Data, Guideline Changes, and Adverse Event Management Protocols

Transforming Perioperative MIBC Care in Community Practice: Navigating Emerging Data, Guideline Changes, and Adverse Event Management Protocols

Doctors Remain Trusted Sources for Cancer Info in Post-Pandemic Era

Not surprisingly, trust in government health agencies for cancer info has dipped

Groundbreaking Pancreatic Cancer Drug Shows Promise in Lung Cancer

Response rates with daraxonrasib ranged from 31% to 37% in previously treated RAS-mutant NSCLC

Blood Cancer's First New Drug in 29 Years; AI for Mammography? Phase III Myeloma Win

News, features, and commentary about cancer-related issues

More Evidence Ties Microplastics to Lung Cancer

Observational study shows greater microplastic burden in patients with lung malignancy

Nationwide Epinephrine Recall; FBI's Fauci Probe; Bruce Campbell's Cancer

Health news and commentary gathered by MedPage Today staff

9/11's Latest Wave of Cancers, 25 Years On

The health ramifications of the attack persist

Todays Updates

Transforming Perioperative MIBC Care in Community Practice: Navigating Emerging Data, Guideline Changes, and Adverse Event Management Protocols

Transforming Perioperative MIBC Care in Community Practice: Navigating Emerging Data, Guideline Changes, and Adverse Event Management Protocols

Doctors Remain Trusted Sources for Cancer Info in Post-Pandemic Era

Not surprisingly, trust in government health agencies for cancer info has dipped

Groundbreaking Pancreatic Cancer Drug Shows Promise in Lung Cancer

Response rates with daraxonrasib ranged from 31% to 37% in previously treated RAS-mutant NSCLC

Blood Cancer's First New Drug in 29 Years; AI for Mammography? Phase III Myeloma Win

News, features, and commentary about cancer-related issues

More Evidence Ties Microplastics to Lung Cancer

Observational study shows greater microplastic burden in patients with lung malignancy

Nationwide Epinephrine Recall; FBI's Fauci Probe; Bruce Campbell's Cancer

Health news and commentary gathered by MedPage Today staff

9/11's Latest Wave of Cancers, 25 Years On

The health ramifications of the attack persist

Latest News

The Paradigm Shift in Neuro-Oncology: Precision Decision-Making for IDH1/2 Mutated Gliomas

All that Glitters Isn't Gold: An Exploration of Parkinson's Disease Mimics

Assay measures phosphorylated tau 217, an indicator of amyloid pathology

Cognitive function improved in small placebo-controlled trial

News and commentary from the world of neurology and neuroscience

At least 1 in 4 pro players who died from 2016 to 2021 had the progressive brain disorder

News All Time

Iron, Selenium, and Dementia; Epilepsy and Education; Brain Death Conversations

News and commentary from the world of neurology and neuroscience

MS Drugs Differ Most on Relapses, Not Disability, Real-World Study Shows

In new patients, disability score changes were similar over 2 years regardless of treatment

Autism Tied to 14-Year Gap in Life Expectancy

Large U.S. study points to preventable causes of excess mortality

Trial Confirms IVIG as Useful Therapy for Inflammatory Myopathy

But thromboembolic risks could be significant

First Therapy to Target Muscle Loss in Spinal Muscular Atrophy Gets FDA Approval

Motor function may improve with adjunctive apitegromab

Alzheimer's and Liver Enzymes; Pivotal Trial Hold; Lasker Awards Honor Brain Science

News and commentary from the world of neurology and neuroscience

Aging Doctors Face a Patchwork of Cognitive Screening Policies, Study Shows

Unlike pilots, judges, and air traffic controllers, physicians rely largely on self-regulation

Trump's Surgeon General Pick Grilled Over Vaccine Stance

"I do not believe childhood vaccines cause autism," Saphier said

Case Report: What Caused This Man's Acute Paralysis?

36-year-old Asian man had epidural steroid injection for persistent back pain after unsuccessful chiropractic treatments

Man Presents With Episodic, One-Sided Facial Paralysis

Uncommon presentation of MS detailed in case report

FDA-Ordered Studies for Drugs and Devices on the Market for Years Still Aren't Done

Agency's reliance on postmarketing studies reflects a balancing act

Gene Therapy for Sanfilippo Syndrome Gets FDA Nod

Treatment is the first for MPS type IIIA

Depression Drug Trials Paused Over Side-Effect Concerns

Xenon Pharmaceuticals on Thursday said it has temporarily paused enrolling new patients in clinical studies testing ⁠its experimental drug for major and bipolar depression,...

The 90-Day CPAP Cutoff May Be Too Soon to Measure Success

Data presented at the American Thoracic Society (ATS) 2026 show many early CPAP nonadherers reach clinically meaningful use within a year, challenging CMS's rigid 90 day coverage rule.

‘Good First Try’: In Vivo CAR T for Neuro Autoimmune Disease

A single infusion of an off-the-shelf lentiviral vector generates CAR T cells inside patients with refractory neurologic autoimmune disease. But do the results go beyond existing therapies?

Which Therapies Offer the Lowest Relapse Rates in Early MS?

Patients with MS starting B-cell therapies had fewer relapses and less T2 lesion growth, but no measurable difference in disability after 2 years.

Recommended News For You

Tissue-Free ctDNA Predicts Recurrence in Early Breast Cancer

Breast cancer screening in women's 40s can save lives, study says

Scientists call into question safety of potential new anticancer treatment

A novel blood test may enable the early identification of common, fatal cancers.

The pandemic had little impact on mental health symptoms.

Research team uncovers the underpinnings of head and neck cancers

ALK-positive lung cancer trial results show unprecedented progression-free survival.

Recommended Articles For You

Uncovering the Hidden Symptoms of Parathyroid Cancer in Women 

Unlocking The Causes And Risk Factors Of Breast Cancer 

Personalizing Cancer Care: Microbiome Advances, Challenges, and Future Directions 

The Latest Research on Chronic Granulomatous Disease and Promising New Treatments  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Enthusiasm for Transplant-Free Strategies for Low-Risk Relapsed Hodgkin Lymphoma

2.

New target points to combination therapy for thwarting multidrug resistance in cancer treatment

3.

Low-Dose Radiation Provides Almost Perfect Control Over Slow-Growing Lymphoma.

4.

Compared to previous estimates, a greater number of patients participate in cancer treatment trials.

5.

In Acute Myeloid Leukemia Diagnosed Recently, FLT3 Inhibitor Is Very Effective.

1.

Exploring Dyscrasias: Uncovering the Causes and Treatments of Unusual Blood Disorders

2.

Liquid Biopsies in Hematology: A Window into the Disease

3.

Beyond the Tumor: Emerging Frontiers in Cancer Systems Biology

4.

Next-Generation Sequencing in Oncology: Unlocking the Future of Precision Medicine

5.

Unlocking the Potential of Onivyde: A New Hope for Cancer Treatment

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Understanding Common Causes of Abnormal Blood Counts

2.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV

3.

Efficient Management of First line ALK-rearranged NSCLC - Part VIII

4.

The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion

5.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot